Timothy A. Springer - Director, 10%+ Owner at Cartesian Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director, 10%+ Owner
Issuer Symbol: RNAC on Nasdaq
All Insider Reports: All Insider Reports

Timothy A. Springer - trading volume in the past year for Cartesian Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+238,938	100%	$12.11	+$2,893,671
Sells
Net	+238,938	100%		+$2,893,671

Holdings reported by Timothy A. Springer for Cartesian Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	8,646,285	$73,061,108	$8.45	02 Jan 2026	Direct
Common Stock	656,513	$5,547,534	$8.45	02 Jan 2026	Indirect
Common Stock	330,695	$2,794,372	$8.45	02 Jan 2026	By wife
Stock Option (Right to Buy)	7,800	$6,162	$0.7900	02 Jan 2026	Direct	Common Stock	7,600

Transactions reported by Timothy A. Springer for Cartesian Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.